Molecular modeling studies on 11H-dibenz[b,e]azepine and Dibenz[b,f][1,4]oxazepine derivatives as potent agonists of the human TRPA1 receptor

Molecules

Volumn 15, Issue 12, 2010, Pages 9364-9379

  Ai, Yong ^a   Song, Fa Jun ^a   Wang, Shao Teng ^a   Sun, Qiang ^a   Sun, Ping Hua ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

11H dibenz b,e azepines; CoMFA; CoMSIA; Dibenz b,f 1,4 oxazepines; TRPA1

Indexed keywords

AZEPINE DERIVATIVE; CALCIUM CHANNEL; NERVE PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRPA1 PROTEIN, HUMAN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG POTENTIATION; HUMAN;

AZEPINES; CALCIUM CHANNELS; COMPUTER SIMULATION; HUMANS; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 78650649188     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15129364     Document Type: Article

References (30)

1. McMahon, S.B.; Wood, J.N. Increasingly irritable and close to tears: TRPA1 in inflammatory pain. Cell 2006, 124, 1123-1125.
2. Karashima, Y.; Prenen, J.; Meseguer V.; Owsianik, G.; Voets, T.; Nilius, B. Modulation of the transient receptor potential channel TRPA1 by phosphatidylinositol 4,5-biphosphate manipulators. Eur. J. Physiol. 2008, 457, 77-89.
3. Bandell, M.; Story, G.M.; Hwang, S.W.; Viswanath, V.; Eid, S.R.; Petrus, M.J.; Earley, T.J.; Patapoutian, A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41, 849-857.
4. Corey, D.P.; Garcia-Anoveros, J.; Holt, J.R.; Kwan, K.Y.; Lin, S.Y.; Vollrath, M.A.; Amalfitano, A.; Cheung, E.L.; Derfler, B.H.; Duggan, A.; Geleoc, GS.; Gray, P.A.; Hoffman, M.P.; Rehm, H.L.; Tamasauskas, D.; Zhang, D.S. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature 2004, 432, 723-730.
5. Gijsen, H.J.M.; Berthelot, D.; Zaja, M.; Brône, B.; Geuens, I.; Mercken, M. Analogues of morphanthridine and the Tear Gas dibenz[b,f][1,4] oxazepine (CR) as extremely potent activators of the human Transient Receptor Potential Ankyrin 1 (TRPA1) channel. J. Med. Chem. 2010, 53, 7011-7020.
6. Everaerts, W.; Gevaert, T.; Nilius, B.; De Ridder, D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol. Urodyn. 2008, 27, 264-273.
7. Cai, X. Anew tr(i)p to sense pain:TRPA1channel as a target for novel analgesics. Expert Rev. Neurother. 2008, 8, 1675-1681.
8. Bessac, B.F.; Jordt, S.E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology 2008, 23, 360-370.
9. Jordt, S.E.; Bautista, D.M.; Chuang, H.H.; McKemy, D.D.; Zygmunt, P.M.; Hogestatt, E.D.; Meng, I.D.; Julius, D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004, 427, 260-265.
10. Bautista, D.M.; Jordt, S.E.; Nikai, T.; Tsuruda, P.R.; Read, A.J.; Poblete, J.; Yamoah, E.N.; Basbaum, A.I.; Julius, D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124, 1269-1282.
11. Brône, B.; Peeters, P.J.; Marrannes, R.; Mercken, M.; Nuydens, R.; Meert, T.; Gijsen, H.J.M. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol. Appl. Pharmacol. 2008, 231, 150-156.
12. Sybyl 8.1; Tripos Inc.: St. Louis, MO, USA, 2008; Available online: http://www.tripos.com.
13. Ai, Y.; Wang S.T.; Sun, P.H.; Song F.J. Molecular modeling studies of 4,5-Dihydro-1Hpyrazolo[ 4,3-h]quinazoline derivatives as potent CDK2/Cyclin A inhibitors using 3D-QSAR and docking. Int. J. Mol. Sci. 2010, 11, 3705-3724.
14. Xiong, X.Q.; Zhao, D.M.; Bu, P.F.; Liu, Y.; Ren, J.H.; Wang, J.; Cheng, M.S. CoMFA, CoMSIA and eigenvalue analysis on dibenzodioxepinone and dibenzodioxocinone derivatives as cholesteryl ester transfer protein inhibitors. Molecules 2008, 13, 1822-1839.
15. Benabadji, H.S.; Chen, H.F. 3D-QSAR study on diindolylmethane and its analogues with comparative molecular field analysis (CoMFA). Chin. J. Chem. 2003, 21, 20-24.
16. Wellsow, J.; Machullab, H.J.; Kovar, K.A. 3D QSAR of serotonin transporter ligands: CoMFA and CoMSIA studies. Quant. Struct-Act. Relatsh. 2002, 21, 577-589.
17. Liu, H.Y.; Liu, S.S.; Qin, L.T.; M, L.Y. CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors. J. Mol. Model. 2009, 15, 837-845.
18. Yang, Z.Q.; Sun, P.H. 3D-QSAR study of potent inhibitors of phosphodiesterase-4 using a CoMFA approach. Int. J. Mol. Sci. 2007, 8, 714-722
19. Lan, P.; Chen, W.N.; Xiao, G.K.; Sun, P.H.; Chen, W.M. 3D-QSAR and docking studies on pyrazolo[4,3-h]quinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors. Bioorg. Med. Chem. Lett. 2010, 20, 6764-6772.
20. Politi, A.; Durdagi, S.; Moutevelis-Minakakis, P.; Kokotos, G.; Papadopoulos, M.G.; Mavromoustakos, T. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases. Eur. J. Med. Chem. 2009, 44, 3703-3711.
21. Cichero, E.; Cesarini, S.; Spallarossa, A.; Mosti, L.; Fossa, P. Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: Dockinig studies and ligand-based CoMFA and CoMSIA analyses. J. Mol. Model. 2009, 15, 871-884.
22. Cichero, E.; Cesarini, S.; Fossa, P.; Spallarossa, A.; Mosti, L. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: Docking-based CoMFA and CoMSIA analyses. Eur. J. Med. Chem. 2009, 44, 2059-2070.
23. Cichero, E.; Cesarini, S.; Mosti. L.; Fossa, P. CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-,-1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists. J. Mol. Model. 2010, 16, 677-691.
24. Lan, P.; Xie, M.Q.; Yao, Y.M.; Chen, W.N.; Chen, W.M. 3D-QSAR studies and molecular docking on [5-(4-Amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1, 6-biphophatase inhibitors. J. Comput. Aided Mol. Des. 2010, 24, 993-1008.
25. Aher, Y.D.; Agrawal, A.; Bharatam, P.V.; Garg, P. 3D-QSAR studies of substituted 1-(3,3-diphenylpropyl) -piperidinyl amides and ureas as CCR5 receptor antagonists. J. Mol. Model. 2007, 13, 519-529.
26. Lan, P.; Huang, Z.J.; Sun J.R.; Chen W.M. 3D-QSAR and molecular docking studies on fused pyrazoles as p38a mitogen-activated protein kinase inhibitors. Int. J. Mol. Sci. 2010, 11, 3357-3374.
27. Roy, P.P.; Roy, K. On some aspects of variable selection for partial least squares regressionmodels. QSAR Comb. Sci. 2008, 27, 302-313.
28. Basu, A.; Jasu, K.; Jayaprakash, V.; Mishra, N.; Ojha, P.; Bhattacharya, S. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives. Eur. J. Med. Chem. 2009, 44, 2400-2407.
29. Lu, P.; Wei X.; Zhang, R. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase. Eur. J. Med. Chem. 2010, 44, 3413-3419.
30. Golbraikh A.; Tropsha A. Beware of q2! J. Mol. Graph. Model. 2002, 20, 269-276.